BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/30/2021 9:35:11 AM | Browse: 631 | Download: 1718
 |
Received |
|
2021-02-01 16:13 |
|
Peer-Review Started |
|
2021-02-01 16:42 |
|
First Decision by Editorial Office Director |
|
2021-03-29 01:39 |
|
Return for Revision |
|
2021-03-30 23:51 |
|
Revised |
|
2021-05-10 07:46 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-08-04 03:32 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-08-04 07:00 |
|
Articles in Press |
|
2021-08-04 07:00 |
|
Edit the Manuscript by Language Editor |
|
2021-10-21 04:54 |
|
Typeset the Manuscript |
|
2021-11-24 02:50 |
|
Publish the Manuscript Online |
|
2021-11-30 09:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Opinion Review |
| Article Title |
Regulating monocyte infiltration and differentiation: Provide new therapies for colorectal cancer patients with COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ling Bai, Wang Yang, Lei Qian and Jiu-Wei Cui |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Key Research and Development Program of New Coronary Pneumonia and Other Infectious Diseases Prevention Basic Research Orientation Project of China |
2020YFA0707704 |
| the Ministry of Science and Technology of the People’s Republic of China |
2016YFC1303804 |
| the Interdisciplinary Research Funding Program of Jilin University |
101832020DJX083 |
| the outstanding Talent Cultivation Program for Doctoral Students in Norman Bethune Health Science Center of Jilin University |
- |
|
| Corresponding Author |
Jiu-Wei Cui, MD, PhD, Chief Doctor, Professor, Cancer Center, The First Hospital of Jilin University, No. 71 Xinmin Street, Changchun 130021, Jilin Province, China. cuijw@jlu.edu.cn |
| Key Words |
COVID-19; SARS-CoV-2; Monocyte; Macrophage; Colorectal cancer |
| Core Tip |
Not only colorectal cancer (CRC) is susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but its infiltrating monocytes are also affected by SARS-CoV-2. Moreover, after infection, due to the promotion of infiltration and differentiation of monocytes, CRC patients are more likely to develop severe coronavirus disease 2019 (COVID-19). In severe COVID-19, due to the activation of NF-κB and CCR5 signaling pathways, the imbalance of macrophage polarization can further cause the aggravation of cytokine release syndrome. |
| Publish Date |
2021-11-30 09:35 |
| Citation |
Bai L, Yang W, Qian L, Cui JW. Regulating monocyte infiltration and differentiation: Provide new therapies for colorectal cancer patients with COVID-19. World J Clin Cases 2021; 9(34): 10392-10399 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i34/10392.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i34.10392 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
